Read full paper at:
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=50811#.VE29MlfHRK0
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=50811#.VE29MlfHRK0
The action mechanism of ranolazine, an antiangina
drug, could be at least partly metabolic, including inhibition of fatty
acid oxidation and stimulation of glucose utilization in the heart. The
purpose of the present work was to investigate if ranolazine affects
hepatic carbohydrate metabolism. For this purpose, the hemoglobin-free
isolated perfused rat liver was used as the experimental system.
Ranolazine increased glycolysis and glycogenolysis and decreased
gluconeogenesis. These effects were accompanied by an inhibition of
oxygen consumption. The drug also changed the redox state of the NAD+-NADH couple. For the cytosol, increased NADH/NAD+
ratios were observed both under glycolytic conditions as well as under
gluconeogenic conditions. For the mitochondria, increased NADH/NAD+
ratios were found in the present work in the absence of exogenous fatty
acids in contrast with the previous observation of a decreasing effect
when the liver was actively oxidizing exogenous oleate. It seems likely
that ranolazine inhibits gluconeogenesis and increases glycolysis in
consequence of its inhibitory actions on energy metabolism and fatty
acid oxidation and by deviating reducing equivalents in favour of its
own biotransformation. This is in line with the earlier postulates that
ranolazine diminishes fatty acid oxidation, shifting the energy source
from fatty acids to glucose.
Cite this paper
Mito, M. , Castro, C. , Peralta, R. and Bracht, A.
(2014) Effects of Ranolazine on Carbohydrate Metabolism in the
Isolated Perfused Rat Liver. Open Journal of Medicinal Chemistry, 4, 87-95. doi: 10.4236/ojmc.2014.44007.
[1] |
Anderson, J.R. and Nawarskas,
J.J. (2005) Ranolazine, a Metabolic Modulator for the Treatment of
Chronic Stable Angina. Cardiology in Review, 13, 202-210. http://dx.doi.org/10.1097/01.crd.0000161979.62749.e7 |
[2] |
Clarke, B., Spedding, M.,
Patmore, L. and McCormack, J.G. (1993) Protective Effects of Ranolazine
in Guinea-Pig Hearts during Low-Flow Ischaemia and Their Association
with Increases in Active Dehydrogenase. British Journal of Pharmacology,
109, 748-750. http://dx.doi.org/10.1111/j.1476-5381.1993.tb13637.x |
[3] |
Clarke, B., Wyatt, K.M. and
McCormack, J.G. (1996) Ranolazine Increases Active Pyruvate
Dehydrogenase in Perfused Normoxic Rat Hearts: Evidence for an Indirect
Mechanism. Journal of Molecular and Cellular Cardiology, 28, 341-350. http://dx.doi.org/10.1006/jmcc.1996.0032 |
[4] |
McCormack, J.G., Barr, R.L.,
Wolff, A.A. and Lopaschuk, G.D. (1996) Ranolazine Stimulates Glucose
Oxidation in Normoxic, Ischemic and Reperfused Ischemic Rat Hearts.
Circulation, 93, 135-142.
http://dx.doi.org/10.1161/01.CIR.93.1.135 |
[5] |
Fragasso, G. (2007) Inhibition
of Free Fatty Acids Metabolism as a Therapeutic Target in Patients with
Heart Failure. International Journal of Clinical Practice, 61, 603-610. http://dx.doi.org/10.1111/j.1742-1241.2006.01280.x |
[6] |
Marx, S. and Sweeney, M. (2006)
Mechanism of Action of Ranolazine. Archives of Internal Medicine, 166,
1325-1326.
http://dx.doi.org/10.1001/archinte.166.12.1325-b |
[7] |
Verrier, R.L., Kumar, K.,
Nieminen, T. and Belardinelli, L. (2013) Mechanisms of Ranolazine’s Dual
Protection against Atrial and Ventricular Fibrillation. Eurospace, 15,
317-324. http://dx.doi.org/10.1093/europace/eus380 |
[8] |
Kahlig, K.M., Hirakawa, R., Liu,
L., George Jr., A.L., Belardinelli, L. and Rajamani, S. (2014)
Ranolazine Reduces Neuronal Excitability by Interacting with Inactivated
States of Brain Sodium Channels. Molecular Pharmacology, 85, 162-174. http://dx.doi.org/10.1124/mol.113.088492 |
[9] |
Jerling, M., Huan, B.L., Leung,
K., Chu, N., Abdallah, H. and Hussein, Z. (2005) Diltiazem, or
Simvastatin during Combined Administration in Healthy Subjects. Studies
to Investigate the Pharmacokinetic Interactions between Ranolazine and
Keto-Conazole. Journal of Clinical Pharmacology, 45, 422-433.
http://dx.doi.org/10.1177/0091270004273992 |
[10] |
Mito, M.S., Constantin, J.,
Castro, C.V., Ono, M.K.C. and Bracht, A. (2010) Effects of Ranolazine on
Fatty Acid Transformation in the Isolated Perfused Rat Liver. Molecular
and Cellular Biochemistry, 345, 35-44.
http://dx.doi.org/10.1007/s11010-010-0557-8 |
[11] | Williamson, J.R., Browning, E.T. and Scholz, R. (1969) Control Mechanisms of Gluconeogenesis and Ketogenesis. I. Effects of Oleate on Gluconeogenesis in Perfused Rat Liver. Journal of Biological Chemistry, 244, 4607-4616. |
[12] |
Veiga, R.P., Silva, M.H.R.A.,
Teodoro, G.R., Yamamoto, N.S., Constantin, J. and Bracht, A. (2008)
Metabolic Fluxes in the Liver of Rats Bearing the Walker-256 Tumour:
Influence of the Circulating Levels of Substrates and Fatty Acids. Cell
Biochemistry and Function, 26, 51-63. http://dx.doi.org/10.1002/cbf.1398 |
[13] |
Soboll, S., Scholz, R. and
Heldt, H.W. (1978) Subcellular Metabolite Concentrations. Dependence of
Mitochondrial and Cytosolic ATP Systems on the Metabolic State of
Perfused Rat Liver. European Journal of Biochemistry, 87, 377-390. http://dx.doi.org/10.1111/j.1432-1033.1978.tb12387.x |
[14] |
Sugden, M.C., Ball, A.J., Ilk,
V. and Williamson, D.H. (1980) Stimulation of [1-14C]oleate Oxidation to
14CO2 in Isolated Rat Hepatocytes by Vasopressin: Effects of Ca2+. FEBS
Letters, 116, 37-40.
http://dx.doi.org/10.1016/0014-5793(80)80523-0 |
[15] |
Scholz, R. and Bücher, T. (1965)
Hemoglobin-Free Perfusion of Rat Liver. In: Chance, B., Estabrook, R.W.
and Williamson, J.R., Eds., Control of Energy Metabolism, Academic
Press, New York, 393-414.
http://dx.doi.org/10.1016/B978-1-4832-3161-7.50048-3 |
[16] | Bracht, A., Ishii-Iwamoto, E.L. and Kelmer-Bracht, A.M. (2003) O estudo do metabolismo no fígado em perfusao. In: Bracht, A. and Ishii-Iwamoto, E.L., Eds., Métodos de Laboratório em Bioquímica, Editora Manole, Sao Paulo, 275- 289. |
[17] | Bergmeyer, H.U. (1974) Methods of Enzymatic Analysis. Verlag Chemie-Academic Press, Weinheim-London. |
[18] | Clark, L.C. (1956) Monitoring and Control of Blood O2 Tension. Transactions of the American Society of Artificial Internal Organs, 2, 41-49. |
[19] |
Bazotte, R.B., Constantin, J.,
Hell, N.S. and Bracht, A. (1990) Hepatic Metabolism of Meal-Fed Rats:
Studies in Vivo and in the Isolated Perfused Liver. Physiology &
Behavior, 48, 247-253.
http://dx.doi.org/10.1016/0031-9384(90)90308-Q |
[20] |
Thurman, R.G. and Scholz, R.
(1977) Interaction of Glycolysis and Respiration in Perfused Liver.
Changes in Oxygen Uptake Following the Addition of Ethanol. European
Journal of Biochemistry, 75, 13-21.
http://dx.doi.org/10.1111/j.1432-1033.1977.tb11499.x |
[21] |
Kimmig, R., Mauch, T.J. and
Scholz, R. (1983) Actions of Glucagon on Flux Rates in Perfused Rat
Liver. 2. Relationship between Inhibition of Glycolysis and Stimulation
of Respiration by Glucagon. European Journal of Biochemistry, 136,
617-620. http://dx.doi.org/10.1111/j.1432-1033.1983.tb07785.x |
[22] | Sies, H. (1982) Nicotinamide Nucleotide Compartmentation. In: Sies, H., Ed., Metabolic Compartmentation, Academic Press, New York, 205-231. |
[23] |
Gasparin, F.R.S.,
Salgueiro-Pagadigorria, C.L., Bracht, L., Ishii-Iwamoto, E.L., Bracht,
A. and Constantin, J. (2003) Action of Quercetin on Glycogen Catabolism
in the Rat Liver. Xenobiotica, 33, 587-602.
http://dx.doi.org/10.1080/0049825031000089100 |
[24] |
Pereira, S.R.C., Darronqui, E.,
Constantin, J., Silva, M.H.R.A., Yamamoto, N.S. and Bracht, A. (2004)
The Urea Cycle and Related Pathways in the Liver of Walker-256
Tumor-Bearing Rats. Biochimica et Biophysica Acta, 1688, 187-196.
http://dx.doi.org/10.1016/j.bbadis.2003.12.001 |
[25] |
Pivato, L.S., Constantin, R.P.,
Ishii-Iwamoto, E.L., Kelmer-Bracht, A.M., Yamamoto, N.S., Constantin, J.
and Bracht, A. (2006) Metabolic Effects of Carbenoxolone in the Rat
Liver. Journal of Biochemical and Molecular Toxicology, 20, 230-240. http://dx.doi.org/10.1002/jbt.20139 |
[26] |
Acco, A., Comar, J.F. and
Bracht, A. (2004) Metabolic Effects of Propofol in the Isolated Perfused
Rat Liver. Basic & Clinical Pharmacology & Toxicology, 95,
166-174. http://dx.doi.org/10.1111/j.1742-7843.2004.pto950404.x |
[27] |
Wyatt, K.M., Skene, C., Veitch,
K., Hue, L. and McCormack, J.G. (1995) The Antianginal Ranolazine Is a
Weak Inhibitor of the Respiratory Complex I, but with Greater Potency in
Broken or Uncoupled than in Coupled Mitochondria. Biochemical
Pharmacology, 50, 1599-1606. http://dx.doi.org/10.1016/0006-2952(95)02042-X |
[28] |
Scholz, A., Hansen, W. and
Thurman, R.G. (1973) Interaction of Mixed-Function Oxidation with
Biosynthetic Processes. 1. Inhibition of Gluconeogenesis by Aminopyrine
in Perfused Rat Liver. European Journal of Biochemistry, 38, 64-72. http://dx.doi.org/10.1111/j.1432-1033.1973.tb03034.x |
[29] | Orrenius, S. and Sies, H. (1982) Compartmentation of Detoxification Reactions. In: Sies, H., Ed., Metabolic Compartmentation, Academic Press, New York, 485-520. eww141027lx |
评论
发表评论